Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

11 May 2021: Original Paper

Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients

Yong Ho Jeong 1ABCDEFG , Shin Hwang 2ACDEF , Geun Dong Lee 1AB , Se Hoon Choi 1AB , Hyeong Ryul Kim 1AB , Yong-Hee Kim 1AB , Seung-Il Park 1AB , Dong Kwan Kim 1ABCDEFG*

DOI: 10.12659/AOT.930383

Ann Transplant 2021; 26:e930383

Table 2 Recurrence and survival status of patients who underwent pulmonary metastasectomy.

Follow-up period after LT, mean±SD (median, range), year5.4±4.1 (4.0, ~0.2–14.2)
Current status
 Alive without further recurrence7 (13.5%)
 Alive with further recurrence10 (19.2%)
 Non-cancer-related death without recurrence11 (21.2%)
 Cancer-related death24 (46.2%)
Recurrence after metastasectomy34 (65.4%)
Recurrence at more than two sites after metastasectomy16 (30.2%)
Recurrence-free period after metastasectomy, mean±SD (median, range), year1.7±2.4 (0.6, ~0.1–12.0)
Initial recurrence site after metastasectomy
 Lung25 (48.1%)
 Liver10 (19.2%)
 Others (brain, other gastrointestinal organs, bone, etc)20 (38.5%)
LT – liver transplantation. Results reported as n (%), unless otherwise indicated.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358